Condition
Malignant Pleural Mesothelioma
Estimated Enrollment: 390
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double Blind (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment
Study ID Numbers: NGR015|2009-016879-29
Study First Received: March 17, 2010
Last Updated: October 8, 2015
Estimated Primary Completion Date: December 2016
Primary Outcome Measures:
Overall Survival (OS)|Progression-Free Survival (PFS)|Disease Control Rate (DCR)|Duration of Disease Control|Safety and Toxicity according to NCI-CTCAE criteria (version 4.02)|Quality of life (QoL) according to Lung Cancer Symptom Scale|Evaluation of medical care utilization in the two treatment arms
Sponsors and Collaborators:
MolMed S.p.A.
Website Link: https://ClinicalTrials.gov/show/NCT01098266
